查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378846

核酸檢測市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Nucleic Acid Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球核酸檢測市場規模達到29億美元。展望未來， IMARC Group預計到2028年市場規模將達到42億美元，2022-2028年複合年成長率（CAGR）為6.4%。

核酸檢測（NAT）是指篩檢患者血液、組織或尿液中病毒、細菌或致病性核酸的分子技術。它用於法醫檢測並診斷輸血傳染感染、遺傳性疾病和癌症。它涉及透過核酸 (NA) 萃取、目標 NA 擴增和目標擴增子 NA 檢測來合併樣本。測試涉及用於執行聚合酶鍊式反應(PCR)、鏈置換擴增(SDA)、連接酶鍊式反應(LCR)、轉錄介導的擴增(TMA) 和基於NA 序列的擴增(NASBA)過程的試劑盒和耗材。 NAT 也用於識別沒有明顯症狀的疾病並解決錯誤的反應性解釋。

全球性傳染性細菌和病毒性疾病的日益普及是推動市場成長的關鍵因素之一。此外，對先進診斷系統的需求不斷成長也推動了市場的成長。與此一致的是，冠狀病毒病（COVID-19）的爆發也增加了對檢測抗原的 NAT 解決方案的需求。 NAT 廣泛用於傳染病的有效管理和感染源的準確識別。此外，各種技術進步，例如新型生物診斷技術（包括訊號和探針放大系統）的發展，也是其他生長誘導因素。這些創新技術有助於及早發現疾病並最大限度地縮短病毒的傳染期。其他因素，包括廣泛的研發（R&D）活動以及醫療保健基礎設施的改善，預計將進一步推動市場發展。

本報告回答的關鍵問題：

  • 迄今為止，全球核酸檢測市場表現如何，未來幾年又將如何表現？
  • COVID-19對全球核酸檢測市場有何影響？
  • 主要區域市場有哪些？
  • 依產品類型分類的市場是怎麼樣的？
  • 基於技術的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球核酸檢測市場格局如何？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球核酸檢測市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 儀器
    • 市場走向
    • 市場預測
  • 試劑及耗材
    • 市場走向
    • 市場預測

第 7 章：依科技分類的市場

  • TMA- 轉錄介導的擴增
    • 市場走向
    • 市場預測
  • PCR-聚合酶鍊式反應
    • 市場走向
    • 市場預測
  • LCR-連接酶鍊式反應
    • 市場走向
    • 市場預測
  • SDA- 鏈位移放大
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 病理實驗室
    • 市場走向
    • 市場預測
  • 研究機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Agilent Technologies
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Merck KGaA
    • Siemens Healthcare
    • Tecan Group AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2902

Abstract

The global nucleic acid testing market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2022-2028.

Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes. NAT is also used for the identification of diseases with no visible symptoms and resolving false reactive interpretations.

The increasing prevalence of infectious bacterial and viral diseases across the globe represents one of the key factors driving the growth of the market. Furthermore, the increasing demand for advanced diagnostic systems is also driving the market growth. In line with this, the onset of the coronavirus disease (COVID-19) has also enhanced the demand for NAT solutions to detect the antigens. NAT is widely used for the effective management of communicable diseases and accurate identification of the infecting agent. Additionally, various technological advancements, such as the development of novel biological diagnostic techniques, including signal and probe amplification systems, are acting as other growth-inducing factors. These innovative techniques aid in the early detection of the disease and minimizing the infectious period of the virus. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global nucleic acid testing market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, technology and end user.

Breakup by Product Type:

Instruments

Reagents and Consumables

Breakup by Technology:

TMA- Transcription-mediated Amplification

PCR- Polymerase Chain Reaction

LCR- Ligase Chain Reaction

SDA- Strand Displacement Amplification

Others

Breakup by End User:

Hospitals and Clinics

Pathology Laboratories

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, Siemens Healthcare, Tecan Group AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global nucleic acid testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nucleic acid testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nucleic acid testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nucleic Acid Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 TMA- Transcription-mediated Amplification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR- Polymerase Chain Reaction
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 LCR- Ligase Chain Reaction
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 SDA- Strand Displacement Amplification
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pathology Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton, Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthcare
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tecan Group AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nucleic Acid Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Nucleic Acid Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Nucleic Acid Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Nucleic Acid Testing Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Nucleic Acid Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Nucleic Acid Testing Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Nucleic Acid Testing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Nucleic Acid Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Nucleic Acid Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Nucleic Acid Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Nucleic Acid Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Nucleic Acid Testing (TMA- Transcription-mediated Amplification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Nucleic Acid Testing (TMA- Transcription-mediated Amplification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Nucleic Acid Testing (PCR- Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Nucleic Acid Testing (PCR- Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Nucleic Acid Testing (LCR- Ligase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Nucleic Acid Testing (LCR- Ligase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Nucleic Acid Testing (SDA- Strand Displacement Amplification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Nucleic Acid Testing (SDA- Strand Displacement Amplification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Nucleic Acid Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Nucleic Acid Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Nucleic Acid Testing (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Nucleic Acid Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Nucleic Acid Testing (Pathology Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Nucleic Acid Testing (Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Nucleic Acid Testing (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Nucleic Acid Testing (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Nucleic Acid Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Nucleic Acid Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: United States: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Canada: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Canada: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: China: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Japan: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Japan: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: India: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: India: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: South Korea: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: South Korea: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Australia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Australia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Indonesia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Indonesia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia-Pacific: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Germany: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: France: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: France: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United Kingdom: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United Kingdom: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Italy: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Italy: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Spain: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Spain: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Russia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Russia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Brazil: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Mexico: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Mexico: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Nucleic Acid Testing Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Nucleic Acid Testing Industry: SWOT Analysis
  • Figure 80: Global: Nucleic Acid Testing Industry: Value Chain Analysis
  • Figure 81: Global: Nucleic Acid Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nucleic Acid Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nucleic Acid Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Nucleic Acid Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Nucleic Acid Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Nucleic Acid Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Nucleic Acid Testing Market: Competitive Structure
  • Table 7: Global: Nucleic Acid Testing Market: Key Players